Figure 3.
ALC dynamics in BCMA and CD19 CAR-T–treated patients during days 0 through +15.

ALC dynamics in BCMA and CD19 CAR-T–treated patients during days 0 through +15.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal